Bart Vankelecom
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Cardiac Arrhythmias and Treatments 2
- Atrial Fibrillation Management and Outcomes 2
- Cardiac electrophysiology and arrhythmias 1
-
- Poisoning and overdose treatments 1
- Co-authors
- Willem I. M. Willaert (1 shared paper)Marc Vanderheyden (1 shared paper)Philippe Debruyne (3 shared papers)Christine Collienne (1 shared paper)Tom Rossenbacker (2 shared papers)John Roosen (2 shared papers)Bavo Ector (2 shared papers)William C. Wijns (1 shared paper)
In The Last Decade
Bart Vankelecom
5 papers receiving 387 citations
Bart Vankelecom's Hit Papers
Peers
Comparison fields: 5 of 37
- Internal Medicine 45
- Genetics 94
- Cardiology and Cardiovascular Medicine 180
- Hematology 100
- Emergency Medicine 29
Countries citing papers authored by Bart Vankelecom
This map shows the geographic impact of Bart Vankelecom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Vankelecom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Vankelecom more than expected).
Fields of papers citing papers by Bart Vankelecom
This network shows the impact of papers produced by Bart Vankelecom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Vankelecom. The network helps show where Bart Vankelecom may publish in the future.
Co-authors
The 13 scholars most cited alongside Bart Vankelecom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 249 |
| 2 | 2018 | 86 | |
| 3 | 2002 | 49 | |
| 4 | 2021 | 13 | |
| 5 | 2013 | 4 | |
| 6 | 2009 | 1 |
About Bart Vankelecom
Bart Vankelecom is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine, Pharmacology, Rheumatology and Surgery, having authored 6 papers that have together received 402 indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Plant-based Medicinal Research (1 paper), IgG4-Related and Inflammatory Diseases (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Cardiovascular Syncope and Autonomic Disorders (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Internal Medicine (45 citations), Genetics (94 citations), Cardiology and Cardiovascular Medicine (180 citations), Hematology (100 citations) and Emergency Medicine (29 citations). Bart Vankelecom has collaborated with scholars based in Belgium and Ireland. Frequent co-authors include Willem I. M. Willaert, Marc Vanderheyden, Philippe Debruyne, Christine Collienne, Tom Rossenbacker, John Roosen, Bavo Ector, William C. Wijns, Willem Dewilde and Michaël Doumen. Their work appears in journals such as Pacing and Clinical Electrophysiology, The Lancet, Circulation Arrhythmia and Electrophysiology, Journal of Cardiovascular Electrophysiology and Rheumatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.